These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31471352)

  • 1. Position β57 of I-A
    Gioia L; Holt M; Costanzo A; Sharma S; Abe B; Kain L; Nakayama M; Wan X; Su A; Mathews C; Chen YG; Unanue E; Teyton L
    Sci Immunol; 2019 Aug; 4(38):. PubMed ID: 31471352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of Multiple Hybrid Insulin Peptides by a Single Highly Diabetogenic T-Cell Receptor.
    Parras D; Solé P; Delong T; Santamaría P; Serra P
    Front Immunol; 2021; 12():737428. PubMed ID: 34527002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes.
    Wang Y; Sosinowski T; Novikov A; Crawford F; White J; Jin N; Liu Z; Zou J; Neau D; Davidson HW; Nakayama M; Kwok WW; Gapin L; Marrack P; Kappler JW; Dai S
    Sci Immunol; 2019 Apr; 4(34):. PubMed ID: 30952805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
    Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW
    J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
    Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
    J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities.
    Lühder F; Katz J; Benoist C; Mathis D
    J Exp Med; 1998 Feb; 187(3):379-87. PubMed ID: 9449718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo analysis of thymic CD4 T cells in nonobese diabetic mice with tetramers generated from I-A(g7)/class II-associated invariant chain peptide precursors.
    Jang MH; Seth NP; Wucherpfennig KW
    J Immunol; 2003 Oct; 171(8):4175-86. PubMed ID: 14530340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
    Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
    J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion.
    Mohan JF; Petzold SJ; Unanue ER
    J Exp Med; 2011 Nov; 208(12):2375-83. PubMed ID: 22065673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-terminal modification of the insulin B:11-23 peptide creates superagonists in mouse and human type 1 diabetes.
    Wang Y; Sosinowski T; Novikov A; Crawford F; Neau DB; Yang J; Kwok WW; Marrack P; Kappler JW; Dai S
    Proc Natl Acad Sci U S A; 2018 Jan; 115(1):162-167. PubMed ID: 29255035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
    Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
    PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation.
    Michels AW; Ostrov DA; Zhang L; Nakayama M; Fuse M; McDaniel K; Roep BO; Gottlieb PA; Atkinson MA; Eisenbarth GS
    J Immunol; 2011 Dec; 187(11):5921-30. PubMed ID: 22043012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
    Kupfer TM; Crawford ML; Pham K; Gill RG
    J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
    Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
    Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse.
    Crawford F; Stadinski B; Jin N; Michels A; Nakayama M; Pratt P; Marrack P; Eisenbarth G; Kappler JW
    Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16729-34. PubMed ID: 21949373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease.
    Hovhannisyan Z; Weiss A; Martin A; Wiesner M; Tollefsen S; Yoshida K; Ciszewski C; Curran SA; Murray JA; David CS; Sollid LM; Koning F; Teyton L; Jabri B
    Nature; 2008 Nov; 456(7221):534-8. PubMed ID: 19037317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.
    Zhang L; Crawford F; Yu L; Michels A; Nakayama M; Davidson HW; Kappler JW; Eisenbarth GS
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2656-61. PubMed ID: 24550292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymic and postthymic regulation of diabetogenic CD8 T cell development in TCR transgenic nonobese diabetic (NOD) mice.
    Kanagawa O; Shimizu J; Vaupel BA
    J Immunol; 2000 May; 164(10):5466-73. PubMed ID: 10799914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.
    Ridgway WM; Ito H; Fassò M; Yu C; Fathman CG
    J Exp Med; 1998 Dec; 188(12):2267-75. PubMed ID: 9858513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes.
    Yang J; Chow IT; Sosinowski T; Torres-Chinn N; Greenbaum CJ; James EA; Kappler JW; Davidson HW; Kwok WW
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14840-5. PubMed ID: 25267644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.